AIRLINK 74.70 Increased By ▲ 0.41 (0.55%)
BOP 4.93 Decreased By ▼ -0.02 (-0.4%)
CNERGY 4.35 Decreased By ▼ -0.02 (-0.46%)
DFML 39.05 Increased By ▲ 0.25 (0.64%)
DGKC 85.40 Increased By ▲ 0.58 (0.68%)
FCCL 21.14 Decreased By ▼ -0.07 (-0.33%)
FFBL 34.15 Increased By ▲ 0.03 (0.09%)
FFL 9.62 Decreased By ▼ -0.08 (-0.82%)
GGL 10.45 Increased By ▲ 0.03 (0.29%)
HBL 113.40 Increased By ▲ 0.40 (0.35%)
HUBC 136.60 Increased By ▲ 0.40 (0.29%)
HUMNL 11.50 Decreased By ▼ -0.40 (-3.36%)
KEL 4.75 Increased By ▲ 0.04 (0.85%)
KOSM 4.46 Increased By ▲ 0.02 (0.45%)
MLCF 37.73 Increased By ▲ 0.08 (0.21%)
OGDC 139.10 Increased By ▲ 2.90 (2.13%)
PAEL 25.33 Increased By ▲ 0.23 (0.92%)
PIAA 20.50 Increased By ▲ 1.26 (6.55%)
PIBTL 6.61 Decreased By ▼ -0.10 (-1.49%)
PPL 122.60 Increased By ▲ 0.50 (0.41%)
PRL 26.65 No Change ▼ 0.00 (0%)
PTC 14.08 Increased By ▲ 0.15 (1.08%)
SEARL 58.10 Increased By ▲ 0.88 (1.54%)
SNGP 67.24 Decreased By ▼ -0.36 (-0.53%)
SSGC 10.30 Increased By ▲ 0.05 (0.49%)
TELE 8.36 Decreased By ▼ -0.04 (-0.48%)
TPLP 11.14 Increased By ▲ 0.01 (0.09%)
TRG 63.26 Increased By ▲ 0.45 (0.72%)
UNITY 26.60 Increased By ▲ 0.10 (0.38%)
WTL 1.43 Increased By ▲ 0.08 (5.93%)
BR100 7,818 Increased By 7.6 (0.1%)
BR30 25,282 Increased By 132.2 (0.53%)
KSE100 75,056 Increased By 99.5 (0.13%)
KSE30 24,145 Increased By 61.5 (0.26%)

HYDERABAD, (India): The US Food and Drug Administration (FDA) is gathering information on products of Indian spice makers MDH and Everest after Hong Kong halted sales of some of their products for allegedly containing high levels of a cancer-causing pesticide.

“The FDA is aware of the reports and is gathering additional information about the situation,” an FDA spokesperson told Reuters on Friday.

Hong Kong this month suspended sales of three MDH spice blends and an Everest spice mix for fish curries. Singapore ordered a recall of the Everest spice mix as well, saying it contains high levels of ethylene oxide, which is unfit for human consumption and a cancer risk with long exposure.

Reuters is the first to report the US FDA’s review of alleged contamination of Indian spice products.

MDH and Everest did not immediately respond to Reuters requests for comment on this matter.

Everest has previously said its spices are safe for consumption. MDH has not responded to queries about its products so far.

Comments

Comments are closed.